首页> 外文期刊>RMD Open >Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab
【24h】

Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab

机译:甲氨蝶呤联合阿达木单抗治疗类风湿关节炎的疗效和甲氨蝶呤相关毒性

获取原文
           

摘要

Abstract Background Treatment of rheumatoid arthritis (RA) with a combination of methotrexate (MTX)+adalimumab (ADA) is more effective than ADA monotherapy. We assessed the toxicity of different doses of MTX and treatment efficacy of ADA+MTX in two trials
机译:摘要背景甲氨蝶呤(MTX)+阿达木单抗(ADA)联合治疗类风湿关节炎(RA)比ADA单一疗法更有效。我们在两项试验中评估了不同剂量的MTX的毒性和ADA + MTX的治疗效果

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号